The Pfizer is excited to announce the Pfizer’s Sickle Cell Advocacy & Leadership Empowerment (SCALE) Grants.
Donor Name: Pfizer
State: All States
County: All Counties
Type of Grant: Grant
Deadline: 10/15/2025
Size of the Grant: $100,000 to $500,000
Grant Duration: 2 Years
Details:
Individuals living with SCD face persistent lifelong challenges in receiving the care they need due to various factors, including:
- Ongoing stigma and healthcare disparities, attributed to difficulty in accessing appropriate care or having symptoms stigmatized and dismissed when seeking care.
- Shortage of SCD specialists, which can delay transition from pediatric to adult care and potentially lead to disease progression, complications, or even increased mortality.
- Limited access to treatment centers, from those living in rural areas to patients that lack transportation, which potentially leads to delayed care and treatment.
The SCALE Grants program seeks to explore innovative approaches to some of the most persistent challenges in access to care impacting those living with SCD, including, but not limited to:
- Initiatives that evaluate community programs that expand access to care, especially for those in underserved and rural communities.
- Novel advocacy initiatives that raise awareness about SCD-related challenges and unmet healthcare needs.
- Monitoring data systems that identify healthcare gaps that support advocacy and drive policy change.
Grant Categories
To apply for this grant, an application must address one or more of the following categories:
- Assessment & Analysis: Improves and sustains care for people living with SCD by addressing social determinants, access to healthcare, and improving health outcomes. This can include programs that evaluate community outreach models (e.g. mobile health clinics, day hospitals) and rural initiatives. Application should include a thorough plan on how the program metrics will be utilized to shape public policy.
- Policy & Advocacy: Empowers communities to advocate for better access to care by shaping healthcare policy to support the community, hosting policy outreach/grassroots events and strengthening of advocacy skill sets by connecting organizations across states.
- Data Collection/Surveillance: Identifies existing gaps for SCD care across healthcare systems. Programs could include evidence generation and research to support advocacy efforts.
Funding Information
Pfizer will be awarding a total of 150,000 USD in accelerator grants; funding that supports the development and scaling of innovative health solutions or services to improve healthcare outcomes in the SCD space and drive policy change. The amount awarded will depend upon the needs of the project.
Grant Period
Anticipated project length is 12-18 months.
Grant Eligibility
Grant application submissions will need to demonstrate:
- Alignment to at least one of the ‘Grant Categories’ to help improve the lives of those impacted by SCD.
- Quantifiable program impact and ability to measure results/outcomes
- Connection of program elements to potential policy goals/change (short-term/long-term)
- Capacity to deliver quality program(s) to achieve established goals, and plan for policy advocacy.
For more information, visit Pfizer.
